Table 1.
Dog # | Sample type | Tumor cell size* | Phenotype | DCV-negative particles (%) |
---|---|---|---|---|
1 | Biopsy | Large | B-cell | 14.4 |
2 | FNA | Large | B-cell | 20.0 |
3 | Biopsy | Large | B-cell | 11.8 |
4 | Biopsy | Intermediate | T-cell | 5.5 |
5 | Biopsy | Intermediate | B-cell | 6.0 |
6 | Biopsy | Intermediate | B-cell | 4.0 |
7 | Biopsy | Large | B-cell | 9.7 |
8 | Biopsy | Large | B-cell | 13.5 |
9 | Biopsy | Intermediate | T-cell | 5.0 |
10 | Biopsy | Large | B-cell | 23.8 |
11 | Biopsy | Large | B-cell | 4.8 |
12 | Biopsy | Large | B-cell | 3.0 |
13 | Biopsy | Large | B-cell | 10.4 |
14 | FNA | Large | T-cell | 2.4 |
15 | FNA | Large | B-cell | 12.6 |
16 | Biopsy | Large | B-cell | 5.5 |
17 | Biopsy | Large | B-cell | 3.0 |
18 | Biopsy | Large | B-cell | 11.6 |
19 | Biopsy | Large | B-cell | 10.1 |
20 | Biopsy | Large | B-cell | 2.0 |
21 | Biopsy | Large | B-cell | 7.4 |
22 | Biopsy | Large | B-cell | 10.3 |
23 | Biopsy | Large | B-cell | 7.1 |
DCV indicates DyeCycle Violet; 7-AAD, 7-amino-actinomycin D.
Tumor cell size was based on the microscopic appearance of the malignant cells in cytologic preparations and on their forward side scatter as determined by flow cytometry.